Medical Care Technologies Inc.
MDCE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $478 | $296 | $75 | $389 |
| % Growth | 61.4% | 297.2% | -80.8% | – |
| Cost of Goods Sold | $322 | $420 | $28 | $211 |
| Gross Profit | $156 | -$124 | $46 | $179 |
| % Margin | 32.6% | -41.8% | 61.9% | 45.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $101 | $63 | $53 | $70 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $101 | $63 | $53 | $70 |
| Operating Income | $54 | -$187 | -$7 | $109 |
| % Margin | 11.4% | -63.1% | -9.4% | 28% |
| Other Income/Exp. Net | -$2 | -$2 | -$2 | $31 |
| Pre-Tax Income | $52 | -$189 | -$9 | $141 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $52 | -$189 | -$9 | $141 |
| % Margin | 10.9% | -63.7% | -11.9% | 36.1% |
| EPS | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out | 3,283,998 | 3,684,575 | 3,309,575 | 3,309,575 |
| Weighted Avg Shares Out Dil | 3,283,998 | 3,684,575 | 3,309,575 | 3,309,575 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $54 | -$187 | -$7 | $112 |
| % Margin | 11.4% | -63.1% | -9.3% | 28.8% |